TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $362,832 | -64.2% | 43,401 | +6.5% | 0.00% | -66.7% |
| Q2 2023 | $1,012,652 | +74.6% | 40,767 | +4.1% | 0.01% | +80.0% |
| Q1 2023 | $579,897 | +146.0% | 39,174 | +85.9% | 0.01% | +150.0% |
| Q4 2022 | $235,721 | +112.4% | 21,069 | -1.2% | 0.00% | 0.0% |
| Q3 2022 | $111,000 | +40.5% | 21,324 | +14.5% | 0.00% | +100.0% |
| Q2 2022 | $79,000 | -52.1% | 18,624 | +7.6% | 0.00% | -50.0% |
| Q1 2022 | $165,000 | -60.0% | 17,313 | -20.1% | 0.00% | -66.7% |
| Q4 2021 | $412,000 | -34.0% | 21,659 | +15.5% | 0.01% | -40.0% |
| Q3 2021 | $624,000 | +28.7% | 18,745 | +50.0% | 0.01% | +25.0% |
| Q2 2021 | $485,000 | – | 12,499 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |